LAGUNA HONDA HOSPITAL
1. Target Overview & Investment Thesis
LAGUNA HONDA HOSPITAL is a 6-bed under-performing / distressed in SAN FRANCISCO, CA with $219.6M in net patient revenue and a -55.5% operating margin. The hospital serves a payer mix of 60.5% Medicare, 23.0% Medicaid, and 16.5% commercial.
Thesis: Turnaround. Our ML models identify $16.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -55.5% to -48.1% (+736bps).
| Net Revenue HCRIS | $219.6M |
| Current EBITDA COMPUTED | $-121.8M |
| Operating Margin COMPUTED | -55.5% |
| Occupancy HCRIS | 54.4% |
| Revenue / Bed COMPUTED | $36.6M |
| Net-to-Gross HCRIS | 59.5% |
| Distress Probability ML | 13.7% |
2. Market Context & Competitive Position
CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of -55.5% places it below the state median. Among 114 size-comparable peers (3-12 beds), the median margin is -8.7%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (3-12), prioritizing same-state peers. 114 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| LAGUNA HONDA HOSPITAL (Target) | CA | 6 | $219.6M | -55.5% |
| WENATCHEE VALLEY HOSPITAL | WA | 11 | $277.5M | -4.9% |
| FRANCISCAN HEALTH HAMMOND | IN | 10 | $117.7M | -4.3% |
| OCONTO HOSPITAL & MEDICAL CENT | WI | 10 | $80.4M | 1.1% |
| SUMMIT PACIFIC MEDICAL CENTER | WA | 10 | $73.6M | 9.1% |
| PHYSICIANS MEDICAL CENTER | IN | 10 | $60.0M | 24.9% |
| SAMUEL SIMMONDS MEMORIAL HOSPI | AK | 10 | $57.8M | -50.0% |
| INSTITUTE FOR ORTHOPAEDIC SURG | OH | 12 | $55.6M | 39.5% |
| JOYCE EISENBERG KEEFER MEDICAL | CA | 10 | $52.9M | 18.8% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $16.2M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $4.6M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $4.4M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $4.3M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $2.7M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $141K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-121.8M |
| + RCM Uplift | +$16.2M |
| Pro Forma EBITDA | $-105.7M |
| Current Margin | -55.5% |
| Pro Forma Margin | -48.1% |
| WC Released (1x) | $8.4M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-187.4M | $-641.9M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-187.4M | $-767.0M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-168.7M | $-774.5M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-168.7M | $-894.8M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-206.2M | $-661.9M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-206.2M | $-795.0M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Heavy Medicare dependence | Medicare comprises 60.5% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement |
| Medium | Elevated Medicaid exposure (23.0%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 114 hospitals with 3-12 beds
- Same-state prioritization (n=14)
- Comp margins: P25=-22.5% / P50=-8.7% / P75=2.4%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.